Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dissecting cancer pathways and vulnerabilities with RNAi.

T F Westbrook1, F Stegmeier, S J Elledge

  • 1Howard Hughes Medical Institute, Department of Genetics, Harvard Partners Center for Genetics and Genomics, Harvard Medical School, Boston, Massachusetts 02115, USA.

Cold Spring Harbor Symposia on Quantitative Biology
|July 28, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Some Like It Sweet: Dendritic Cells Add Sugar to Their T(ea).

Cell·2020
Same author

TERT promoter mutations and monoallelic activation of TERT in cancer.

Oncogenesis·2015
Same author

Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance.

Oncogene·2015
Same author

Targeted cancer therapies in the twenty-first century: lessons from imatinib.

Clinical pharmacology and therapeutics·2010
Same author

Sensing and signaling DNA damage: roles of Rad17 and Rad9 complexes in the cellular response to DNA damage.

Harvey lectures·2003
Same author

The FHA domain, a phosphoamino acid binding domain involved in the DNA damage response pathway.

Cold Spring Harbor symposia on quantitative biology·2003
Same journal

Functional and Mechanistic Interplay of Host and Viral Alternative Splicing Regulation during Influenza Infection.

Cold Spring Harbor symposia on quantitative biology·2020
Same journal

Myriad RNAs and RNA-Binding Proteins Control Cell Functions, Explain Diseases, and Guide New Therapies.

Cold Spring Harbor symposia on quantitative biology·2020
Same journal

Small RNA Function in Plants: From Chromatin to the Next Generation.

Cold Spring Harbor symposia on quantitative biology·2020
Same journal

U1 snRNP Telescripting Roles in Transcription and Its Mechanism.

Cold Spring Harbor symposia on quantitative biology·2020
Same journal

The THO Complex as a Paradigm for the Prevention of Cotranscriptional R-Loops.

Cold Spring Harbor symposia on quantitative biology·2020
Same journal

Biophysical Properties of HP1-Mediated Heterochromatin.

Cold Spring Harbor symposia on quantitative biology·2020
See all related articles

Identifying novel cancer genes and drug targets is crucial. RNA interference (RNAi) in mammalian cells enables genome-scale functional studies, aiding the discovery of cancer-signaling networks and vulnerabilities.

Area of Science:

  • Genetics
  • Molecular Biology
  • Cancer Research

Background:

  • Molecular-targeted cancer therapies rely on understanding cancer pathogenesis networks.
  • Functional annotation of human genes is incomplete, leaving many cancer-relevant genes undiscovered.
  • Genetic screens in invertebrates offer insights but lack tools in mammalian cells.

Purpose of the Study:

  • To discuss the application of RNA interference (RNAi) for cancer gene discovery.
  • To explore RNAi-based approaches for elucidating cancer-signaling networks.
  • To identify potential cancer vulnerabilities using genome-scale genetic screens.

Main Methods:

  • Utilizing RNA interference (RNAi) for gene expression suppression in mammalian cells.
  • Applying genome-scale genetic screens to identify cancer-relevant genes.

Related Experiment Videos

  • Analyzing signaling networks involved in cancer pathogenesis.

    • Main Results:

    • RNAi has revolutionized mammalian genetics, enabling large-scale functional gene decoding.
    • RNAi facilitates the identification of previously unknown cancer-relevant genes.
    • This approach aids in uncovering critical cancer vulnerabilities.

    Conclusions:

    • RNAi-based genetic approaches are powerful tools for cancer research.
    • Understanding cancer networks through RNAi can lead to new therapeutic targets.
    • Further application of RNAi will enhance the discovery of cancer vulnerabilities.